Gilenya Clinical Trials Gilenya RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Condition:   Relapsing Multiple Sclerosis Intervention:   Drug: Fingolimod Sponsor:   Novartis Pharmaceuticals Not yet recruiting - verified August 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2017 Category: Research Source Type: clinical trials